Skip to main content

Table 1 Clinical characteristics of AMI patients and the control subjects

From: Circulating miR-26a-1, miR-146a and miR-199a-1 are potential candidate biomarkers for acute myocardial infarction

Variable AMI group (n = 31) Control group (n = 27) p-value
Male/Female (n/n)1 25/6 19/8 0.362
Age (years)2 61.1 ± 10.0 60.1 ± 12.2 0.379
BMI (kg/m2)2 25.5 ± 2.1 24.8 ± 4.1 0.368
Smoking status
 Current smoker (%)1 58.1% 44.4% 0.188
 Former smoker (%)1 9.7% 0 0.370
 Never (%)1 32.2% 55.6% 0.074
Hypertension (%)1 71.0% 22.2% < 0.001**
Diabetes (%)1 32.3% 11.1% 0.054
SBP (mmHg)3 129.4 ± 22.0 124.6 ± 11.9 0.258
DBP (mmHg)3 78.8 ± 12.8 71.9 ± 7.5 0.017*
Heart rate (beats/minutes)3 73.3 ± 12.2 77.3 ± 9.3 0.052
Killip class at admission ≥ II (%)1 32.3 0 0.001**
Blood glucose (mmol/L)3 6.7 ± 2.9 5.4 ± 2.0 0.720
Total cholesterol (mmol/L)3 4.7 ± 1.0 4.2 ± 1.5 0.119
Triglycerides (mmol/L)3 2.3 ± 3.0 1.1 ± 0.6 0.002**
HDL (mmol/L)3 1.1 ± 0.3 1.2 ± 0.5 0.307
LDL (mmol/L)3 2.7 ± 0.8 2.5 ± 1.1 0.293
WBC (× 109/L)3 9.2 ± 3.0 7.7 ± 3.2 0.067
Cr (μmol/L)3 63.4 ± 14.0 70.0 ± 23.1 0.176
NT-proBNP (pg/ml)3 1497.5 ± 1667.4 77.2 ± 86.8 0.001**
CK-MB (U/L)3 47.5 ± 72.1 12.1 ± 8.9 < 0.001**
MYO (μg/L)3 55.4 ± 22.8 35.4 ± 10.7 0.250
Hs-cTNT (μg/L)3 2.08 ± 2.11 0.002 ± 0.000 < 0.001**
Concurrent medications
 ACE inhibitors (%)1 80.6% 0 < 0.001**
 Beta-blockers (%)1 96.8% 0 < 0.001**
 Nitrates (%)1 96.8% 3.7% < 0.001**
 Statins (%)1 100.0% 0 < 0.001**
 Aspirins (%)1 100.0% 0 < 0.001**
 Colpidogrel (%)1 41.9% 0 < 0.001**
  1. BMI Body mass index, DM Diabetes mellitus, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, TG total triglycerides, HDL high-density lipoprotein, LDL low-density lipoprotein, WBC white blood cell, Cr creatinine, CK-MB Creatine Kinase-MB, Hs-TNT troponin T. Data are shown as the mean ± SD; 1Chi-square tests for the differences in the distribution frequencies between AMI patients and controls; 2Student’s t test for the differences between the AMI and control groups; 3Mann-Whitney U test for the differences between the AMI and control groups